Overview
Xiaoping Su practices in Wenzhou, China. Su is highly rated in 6 conditions, according to our data. Their top areas of expertise are Renal Cell Carcinoma (RCC), Leukemia, Acute Myeloid Leukemia (AML), and Liver Cancer.
Their clinical research consists of co-authoring 164 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Renal Cell Carcinoma (RCC)Su isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Advanced
- Acute Megakaryoblastic Leukemia
- Acute Myeloid Leukemia (AML)
- LeukemiaSu isAdvanced. Learn about Leukemia.
- Liver CancerSu isAdvanced. Learn about Liver Cancer.
- Neuroendocrine Tumor
- Experienced
- Actinic KeratosisSu isExperienced. Learn about Actinic Keratosis.
- Acute Lymphoblastic Leukemia (ALL)
- Adult Soft Tissue Sarcoma
- Alpha ThalassemiaSu isExperienced. Learn about Alpha Thalassemia.
- Alpha Thalassemia X-Linked Intellectual Disability Syndrome
- Basal Cell Skin CancerSu isExperienced. Learn about Basal Cell Skin Cancer.